Lundbeck has completed the acquisition of all outstanding shares of Longboard Ph...
The US FDA has approved AstraZeneca's Imfinzi (durvalumab), to treat limited-sta...
US police have confirmed that Brian Thompson was fatally shot outside an investo...
An open-label Phase III trial showed that participants using Zepbound saw 47% gr...
Maze Therapeutics has completed a Series D financing round, raising $115m to pro...
Ipsen has entered an exclusive worldwide licensing agreement with Biomunex Pharm...
Takeda has signed an agreement to receive an exclusive global licence from Keros...
Many machines are required for pharmaceutical milling processes. Can you reduce ...
A change in FTC leadership would likely see a relaxation of antitrust enforcemen...
Drugs such as Cobenfy could reshape the antipsychotic market, providing a more n...
CBC Group has completed the strategic acquisition of UCB's mature neurology and ...
The research team at UQ has secured a grant of $344,000 from the National Founda...
The HIV vaccine space has seen dwindling research activity as drug manufacturers...
J&J is seeking approval of TREMFYA for paediatric conditions with the submission...
Novartis has entered a worldwide licence and partnership agreement with PTC Ther...
The MHRA has also granted approval to Faron Pharmaceuticals to conduct the BEXMA...